What data looks like for this category
Biologics investment research data mainly comes from public clinical trial databases, pharmaceutical company R&D pipeline announcements, regulatory agency approval documents, professional medical journals, and pharmaceutical companies' quarterly/annual financial reports. The update rhythm is not fixed: clinical trial data updates with subject enrollment, interim analysis, and completion progress; regulatory approval documents release alongside drug approval milestones; financial reports update quarterly and annually. Document structures vary significantly: a single clinical trial report includes subject groups, efficacy indicators, safety data, and other content; R&D pipeline documents list drug names, indications, and development stages in an itemized format; financial reports include financial fields such as pipeline investment. Common fields include IC50 value, median lethal dose LD50, with units involving professional measurement standards such as nmol/L and mg/kg.
What constraints do these characteristics impose on vector models and indexing
Professional fields and units of biologic data require vector models to have domain-adapted semantic encoding capabilities. Without such capabilities, accurate matching of professional term associations related to investment research cannot be achieved. Document length spans a wide range: from hundreds of characters for pipeline entries to tens of thousands of characters for clinical trial reports. This requires indexing to support flexible segmentation while retaining contextual associations across segments, avoiding splitting of professional indicator paragraphs. Data updates have no fixed cycle, and a single update may involve partial modifications to a single document. This requires indexing to support incremental update logic, avoiding resource consumption caused by full reindexing. Additionally, investment research scenarios require filtering recall results by metadata such as drug name and development stage. Indexing must support precise filtering by metadata dimensions to improve retrieval targeting.
How to set configurations
| Configuration Item | Recommended Values | Rationale |
|---|---|---|
chunk_size | 800–1200 characters | Balances semantic integrity and retrieval efficiency for long biologic texts, avoiding encoding inaccuracy caused by splitting professional terms |
chunk_overlap | 150–200 characters | Retains semantic associations of continuous paragraphs in documents such as clinical trial reports and financial reports, preventing breakage of professional indicator information across segments |
recall_top_k | Top 10–15 results | Covers multi-dimensional information required for investment research (efficacy, safety, financial data), while controlling context length to not exceed model limits |
similarity_threshold | 0.75–0.85 | Filters low-relevance general documents, ensuring recall results are strongly associated with biologic professional content |
vector_db_shard_count | 2–4 shards | Adapts to the feature of large vector data volume for single documents, improves retrieval concurrency, and avoids query timeouts |
metadata_filter_enabled | Enabled | Supports filtering recall results by fields such as drug name and clinical trial stage, accurately matching targeted retrieval needs of investment research scenarios |
The parameter values provided on this page are all conventional recommendations used as a starting point for configuration. Actual values are affected by material form, data volume, and business rules. Specific issues require case-by-case analysis, and it is recommended to test on your own samples before finalizing.
Three common mistakes
- Phenomenon: Retrieval results are empty or irrelevant after custom index configuration. Cause: Core professional fields such as IC50 and indications are not included in the index metadata or segmentation extraction scope, resulting in vector encoding not covering core investment research information.
- Phenomenon: A 504 timeout error is returned when connecting a custom Qdrant vector database. Cause: Correct Qdrant cluster access port and API key are not configured, or network policies restrict cross-domain access.
- Phenomenon: The Hunyuan vector model fails to generate valid vectors after configuration. Cause: The API key and regional node of the Hunyuan vector model are not correctly configured on the platform, or call parameters do not match the input format required by the model.
How to confirm the configuration is correct
- Upload a single biologic clinical trial abstract, check whether the retrieval results include matching professional content such as efficacy indicators and indications.
- View the vector database console, confirm that vector entries for the corresponding document have been generated, and metadata fields such as drug name and trial stage are complete.
- Test the custom vector database connection, verify that retrieval results can be returned normally without connection errors.
- Adjust the similarity threshold, observe changes in the relevance of retrieval results, and confirm that the threshold meets the matching needs of investment research scenarios.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-14.